TrademarkDir
GOODBYE GELS
DEAD

Serial Number

97039098

Owner

Marius Pharmaceuticals, LLC

Attorney

Jeffrey J. Ellison

Filing Date

Sep 22, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GOODBYE GELS Trademark

Serial Number: 97039098

GOODBYE GELS is a trademark filed by Marius Pharmaceuticals, LLC on September 22, 2021. The trademark is classified under Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently no longer active.

Owner Contact Info

Marius Pharmaceuticals, LLC (18 trademarks)

8601 Six Forks Road, Suite 630
Raleigh, NC 27615

Entity Type: 16

Trademark Details

Filing Date

September 22, 2021

Registration Date

Not Registered

Published for Opposition

February 15, 2022

Goods & Services

Printed materials, namely, brochures, booklets, and teaching materials in the field of achieving endocrine balance

Providing a website featuring medical information in the field of achieving endocrine balance

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 14, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 14, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 11, 2024 EXRA
SOU EXTENSION 5 GRANTED
Oct 11, 2024 EX5G
SOU EXTENSION 5 FILED
Oct 11, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 11, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 13, 2024 EXRA
SOU EXTENSION 4 GRANTED
Apr 12, 2024 EX4G
SOU EXTENSION 4 FILED
Apr 12, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 12, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 12, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 12, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 12, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 14, 2023 EXRA
SOU EXTENSION 3 GRANTED
Oct 12, 2023 EX3G
SOU EXTENSION 3 FILED
Oct 12, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 12, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 14, 2023 EXRA
SOU EXTENSION 2 GRANTED
Apr 12, 2023 EX2G
SOU EXTENSION 2 FILED
Apr 12, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 12, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 14, 2022 EXRA
SOU EXTENSION 1 GRANTED
Oct 12, 2022 EX1G
SOU EXTENSION 1 FILED
Oct 12, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 12, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 12, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 15, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 26, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 7, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 7, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 7, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 7, 2022 CNEA
ASSIGNED TO EXAMINER
Jan 7, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2021 NWOS

Related Trademarks

More from this Owner

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE

BASE HEALTHCARE ADEQUATE TESTOSTERONE THERAPY

BASE HEALTHCARE ADEQUATE TESTOSTERONE THERAPY

BASE HEALTHCARE ADEQUATE TESTOSTERONE THERAPY

BASE HEALTHCARE ADEQUATE TESTOSTERONE THERAPY